# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 5d05:A (1.75) | BS01 | MN | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
2 | 5d05:A (1.75) | BS02 | PEP | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
3 | 5d05:A (1.75) | BS03 | PHE | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
4 | 5d05:B (1.75) | BS01 | MN | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
5 | 5d05:B (1.75) | BS02 | PEP | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
6 | 5d05:B (1.75) | BS03 | PHE | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
7 | 5d05:C (1.75) | BS01 | MN | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
8 | 5d05:C (1.75) | BS02 | PEP | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
9 | 5d05:C (1.75) | BS03 | PHE | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
10 | 5d05:D (1.75) | BS01 | MN | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
11 | 5d05:D (1.75) | BS02 | PEP | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A | |
12 | 5d05:D (1.75) | BS03 | PHE | 2.5.1.54 | GO:0003849 ... | Q9K169 | N/A |